Literature DB >> 23791019

Epstein-Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration.

Aditi Sengupta Banerjee1, Anindita Deb Pal, Subrata Banerjee.   

Abstract

Epstein-Barr virus (EBV) encoded small, non-coding, non-polyadenylated RNAs, known as EBERs are the most abundantly expressed viral transcripts in latently EBV infected cells. We found the specific role of EBERs in cell cycle progression, resistance against chemotherapeutic drug and cellular invasion in gastric cancer cells in vitro. Ectopic expression of EBERs upregulates the expression of IL-6 and activate its downstream STAT3, which is significantly involved in downregulating the expression of cell cycle inhibitor genes p21 and p27. Stable expression of EBERs regulates the activation of pFAK and pPAK1 and the expression of anti-metastatic genes RhoGDI and KAI-1 in gastric cancer cells. In addition, administration of neu-IL-6 antibody and dominant negative STAT3β reduces chemoresistance and inhibits invasion of EBERs-expressing gastric cancer cells. Our results thus revealed a novel role of EBERs in the coordination of IL-6-STAT3 signaling pathway to chemoresistance and cellular migration.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemoresistance; EBERs; Epstein–Barr virus; Gastric cancer; IL-6; Migration; STAT3

Mesh:

Substances:

Year:  2013        PMID: 23791019     DOI: 10.1016/j.virol.2013.05.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

Review 1.  Molecular pathogenesis and emerging targets of gastric adenocarcinoma.

Authors:  Abby Ivey; Hillary Pratt; Brian A Boone
Journal:  J Surg Oncol       Date:  2022-06       Impact factor: 2.885

Review 2.  Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.

Authors:  Deilson Elgui de Oliveira; Bárbara G Müller-Coan; Joseph S Pagano
Journal:  Trends Microbiol       Date:  2016-04-07       Impact factor: 17.079

3.  EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma.

Authors:  Zhi Li; Yumei Duan; Shiyue Cheng; Yan Chen; Yanxin Hu; Lu Zhang; Jiang He; Qiong Liao; Lifang Yang; Lun-Quan Sun
Journal:  Oncotarget       Date:  2015-09-15

4.  Epstein-barr virus in gastro-esophageal adenocarcinomas - single center experiences in the context of current literature.

Authors:  Vera Genitsch; Alexander Novotny; Christian A Seiler; Dino Kröll; Axel Walch; Rupert Langer
Journal:  Front Oncol       Date:  2015-03-26       Impact factor: 6.244

Review 5.  Viral Oncology: Molecular Biology and Pathogenesis.

Authors:  Uyen Ngoc Mui; Christopher T Haley; Stephen K Tyring
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

Review 6.  Gastric cancer: genome damaged by bugs.

Authors:  Yanan Zhao; Jinglin Zhang; Alfred S L Cheng; Jun Yu; Ka Fai To; Wei Kang
Journal:  Oncogene       Date:  2020-03-02       Impact factor: 9.867

Review 7.  Landscape of EBV-positive gastric cancer.

Authors:  Motonobu Saito; Koji Kono
Journal:  Gastric Cancer       Date:  2021-07-22       Impact factor: 7.370

Review 8.  Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis.

Authors:  Aldo Giudice; Giovanni D'Arena; Anna Crispo; Mario Felice Tecce; Flavia Nocerino; Maria Grimaldi; Emanuela Rotondo; Anna Maria D'Ursi; Mario Scrima; Massimiliano Galdiero; Gennaro Ciliberto; Mario Capunzo; Gianluigi Franci; Antonio Barbieri; Sabrina Bimonte; Maurizio Montella
Journal:  Oxid Med Cell Longev       Date:  2016-02-10       Impact factor: 6.543

9.  Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers.

Authors:  Swarnendu Tripathi; Louiza Belkacemi; Margaret S Cheung; Rathindra N Bose
Journal:  Cancer Inform       Date:  2016-01-20

10.  Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.

Authors:  Inhye Jeong; Sun Kyoung Kang; Woo Sun Kwon; Hyun Jeong Kim; Kyoo Hyun Kim; Hyun Myong Kim; Andre Lee; Suk Kyeong Lee; Thomas Bogenrieder; Hyun Cheol Chung; Sun Young Rha
Journal:  J Cell Mol Med       Date:  2018-09-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.